...May 14, 2020 NEW YORK (S&P Global Ratings) May 14, 2020--S&P Global Ratings today assigned its '###-' rating to Boston Scientific Corp.'s proposed senior unsecured notes. We expect the company to use the proceeds to refinance some of its short-term debt. Our '###-' issuer credit rating and stable outlook on Boston Scientific are unaffected by the debt issuance. Our ratings on Boston Scientific reflect the company's strong and stable business, including its broad portfolio of market-leading medical devices used in diverse specialties, its expansive geographic footprint, its limited competition, and the high barriers to entry in these product markets. The rating also reflects our expectation that Boston Scientific's proactive cost-reduction and cash-preservation measures will help contain COVID-19's impact in 2020. While we expect the company's leverage to temporarily increase above 4x in 2020 because of COVID-19, we believe the strong growth prospects of its product portfolio will help maintain...
